CAS No.: | 34444-01-4 |
---|---|
Formula: | C18h18n6o5s2 |
EINECS: | 252-030-0 |
Type: | Pharmaceutical Intermediates |
Appearance: | Powder |
Quality: | Industrial |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Synonyms: 7-[(2-Hydroxy-2-phenylacetyl)amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid CAS NO.: 34444-01-4 MF: C18H18N6O5S2 MW: 462.50 EINECS NO.: 252-030-0 InChI: 1S/C18H18N6O5S2/c1-23-18(20-21-22-23)31-8-10-7-30-16-11(15(27)24(16)12(10)17(28)29)19-14(26)13(25)9-5-3-2-4-6-9/h2-6,11,13,16,25H,7-8H2,1H3,(H,19,26)(H,28,29) Appearance:white or off-white crystalline powder Assay: 99.0%min Standard: CP/USP/EP/BP |
.
Name | CAS No. | Purity |
Magnesium Taurate | 334824-43-0 | 98.0% |
Galantamine Hydrobromide | 69353-21-5 | 98.0% |
Tianeptine | 66981-73-5 | 99.0% |
Tianeptine sodium | 30123-17-2 | 99.0% |
Tianeptine hemisulfate monohydrate (THM) | 1224690-84-9 | 99.0% |
9-ME-BC(9-Methyl-9H-beta-carboline) | 2521/7/5 | 99.0% |
Agomelatine | 138112-76-2 | 99.0% |
6-Paradol 98% | 27113-22-0 | 98% Oil form |
6-Paradol 50% | 27113-22-0 | 50% Powder form |
Nicotinamide Riboside Chloride(NRC) | 23111-00-4 | 98.0% |
Beta-Nicotinamide Mononucleotide(NMN) | 1094-61-7 | 98.0% |
β-Nicotinamide Adenine Dinucleotide(NAD+) | 53-84-9 | 98.0% |
Noopept,GVS-111 | 157115-85-0 | 99.0% |
Piracetam | 7491-74-9 | 99.0% |
Phenibut | 1078-21-3 | 99.0% |
Coluracetam | 135463-81-9 | 99.0% |
N-Methyl-D-aspartic acid(NMDA) | 6384-92-5 | 99.0% |
Alpha GPC(Choline Alfoscerate) | 28319-77-9 | 99% Powder form |
Alpha GPC(Choline Alfoscerate) | 28319-77-9 | 50% Graininess form |
Citicoline | 987-78-0 | 99.0% |
PRL-8-53 | 51352-87-5 | 98.0% |
NSI-189 Phosphate | 1270138-41-4 | 99.0% |
N-Acetyl-L-cysteine ethyl ester | 59587-09-6 | 98.0% |
1-(1-Adamantylcarbonyl) proline | 35084-48-1 | 98.0% |
YK-11 | 431579-34-9 | 99.0% |
TLB-150 | 1208070-53-4 | 99.0% |
OTR-AC | 99.0% | |
5a-hydroxy laxogenin | 56786-63-1 | 99.0% |
Suppliers with verified business licenses